A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes

BACKGROUND: Renal cell carcinoma (RCC) is a third most common tumor of the urinary system. Nowadays, Immunotherapy is a hot topic in the treatment of solid tumors, especially for those tumors with pre-activated immune state. METHODS: In this study, we downloaded genomic and clinical data of RCC samp...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Peng, Wu, Ji-Yue, Zhang, Jian-Dong, Sun, Ze-Jia, Zheng, Xiang, Yu, Bao-Zhong, Cao, Hao-Yuan, Zhang, Fei-Long, Gao, Zi-Hao, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229885/
https://www.ncbi.nlm.nih.gov/pubmed/35739510
http://dx.doi.org/10.1186/s12885-022-09755-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229885/
https://www.ncbi.nlm.nih.gov/pubmed/35739510
http://dx.doi.org/10.1186/s12885-022-09755-2

Ejemplares similares